TMBR - Timber Pharmaceuticals, Inc. Stock Price, Fair Value and News
00
Market Closed as of 31 Jan 2024, 04:00 pm ET
TMBR Stock Valuation Analysis
Valuation
Login to View
Max Portfolio %
Login to View
TMBR Price Action
TMBR RSI Chart
TMBR Stock Valuation Analysis
Valuation
Login to View
Max Portfolio %
Login to View
TMBR Valuation
The Good, Bad and Ugly
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
TMBR Fundamentals
TMBR Revenue
TMBR Earnings
TMBR Profitability
TMBR Investor Care
Revenue & Growth
How Timber Pharmaceuticals, Inc. generates revenue and covers its expenses, based on the latest reported earnings.
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2022 | 929.0K | 540.2K | 273.2K | 83.2K |
| 2021 | 467.6K | 856.5K | 798.9K | 886.5K |
| 2020 | 302.4K | 297.4K | 404.4K | 453.8K |
| 2019 | 57.0K | - | 256.6K | 285.5K |
| 2018 | 73.0K | 72.0K | 79.0K | 71.0K |
| 2017 | 100.0K | 86.0K | 84.0K | 69.0K |
| 2016 | 64.0K | 93.0K | 107.0K | 120.0K |
| 2015 | - | - | - | - |
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
| CEO | Mr. John Koconis M.B.A. |
|---|---|
| WEBSITE | timberpharma.com |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 9 |